Embolotherapy Market Scope And Analysis

  • Report Code : TIPRE00006432
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Embolotherapy Market Analysis Report 2024 to 2031

Buy Now

Embolotherapy Market Report Embolotherapy Market Size and Share Embolotherapy Market Scope and Analysis

Embolotherapy Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3.88 Billion
Market Size by 2031 US$ 7.37 Billion
Global CAGR (2023 - 2031) 8.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Embolic Agent and Support Device
By Disease Indication
  • Cancer
  • Peripheral Vascular Disease
  • Neurological Disease
  • Urological & Nephrological Disorder
  • Gastrointestinal Disorder
By Procedure
  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization
By End User
  • Hospital & Clinic
  • Ambulatory Surgery Center
  • Other End User
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Johnson Johnson Consumer Inc
  • Medtronic
  • Acandis GmbH
  • Terumo Corporation
  • Balt USA LLC
  • Stryker Corporation
  • Guerbet LLC

    • Embolotherapy Market News and Recent Developments

    The Embolotherapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Embolotherapy market are listed below:

    • Terumo Medical Corporation announced the launch of the new AZUR HydroPack Peripheral Coil System in the United States. This coil is designed to find and fill space within the vessel, and it is the only packing coil that uses proprietary hydrogel technology to create a gel core for mechanical occlusion. (Source: Terumo Medical Corporation, Press Release, December 2023)
    • Guerbet announced it would double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions available. (Source: Guerbet, Press Release, March 2022)

    Embolotherapy Market Report Coverage and Deliverables

    The “Embolotherapy Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Embolotherapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Embolotherapy market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Embolotherapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments3
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Embolotherapy market
    • Detailed company profiles